HB1790 - Biologics Competition Act of 2023
US Congress - 118th Congress
Introduced byMariannette J. Miller-Meeks, Nanette Diaz Barragan, Gregory Francis Murphy
Last updated over 1 year ago
5 Co-Sponsors
To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now